The global glaucoma treatment market size was valued at USD 7.91 billion in 2021, growing at a CAGR of 6.98% during 2022 to 2028. Optic nerve damage from glaucoma is a disorder that affects your eyes. High eye pressure usually causes the disorder by damaging the nerve that connects the eye to the brain. Even irreversible vision loss and blindness can result from glaucoma. It is the second most common reason for blindness. Although there is no cure for glaucoma, early treatment with eye drops, laser surgery, and other procedures can frequently avert blindness in some cases.

View detailed report description here https://precisionbusinessinsights.com/market-reports/glaucoma-treatment-market/          

The rise in the prevalence of glaucoma, increased initiatives to raise awareness about glaucoma, and technical breakthroughs in the field of ophthalmology are all driving the growth of the glaucoma treatment market. Glaucoma is quite common among diabetics and people who have additional visual problems such age-related macular degeneration (AMD), cataracts, and dry eye. In accordance with this, the growing senior population, which is more vulnerable to such disorders, is boosting market growth prospects. Furthermore, rising public awareness of health issues and a growing inclination for laser glaucoma surgery are propelling the market forward.

 The global glaucoma treatment market segmentation:
1) By Indication: Open Angle Glaucoma, Closed Angle Glaucoma, Congenital Glaucoma, Secondary Glaucoma, and Others.
2) By Drug Class: Alpha Agonist, Beta Blockers, Prostaglandin Analogs, Carbonic Anhydrase Inhibitors, and Others.
3) By Sales Channel: Hospital Pharmacies, Retail Pharmacies, and Online Sales.

Owing to the increased glaucoma incidences and improved healthcare infrastructure and services, North America is likely to have the greatest share of the market. In addition, numerous groups in the United States are raising public awareness about glaucoma.

Request sample report at  https://precisionbusinessinsights.com/request-sample?product_id=42467                                                                                                    

Some of the major key players in the Glaucoma Treatment Market are Novartis AG, Akorn Incorporated, Inotek Pharmaceuticals, Aerie Pharmaceuticals Inc., Merck & Co., Inc., Pfizer Inc, Abbvie Inc. (Allergan Plc)

Precision Business Insights: 
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:
Mr. Satya
Precision Business Insights | Toll-Free: +1 866 598 1553
Email: [email protected]
Kemp House, 152 – 160 City Road, London EC1V 2NX
Website: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747